Why Automate The Literature Monitoring Process?

A key concern for pharma companies is keeping a close eye on publications that might mention their product and its potential impact on the public. These publications can be extremely dense in volume, commanding careful review of multiple documents across several different sources. This review often needs to take place in a relatively short timeline and with strict reporting requirements.
  
In the EU, for example, the literature search process is tightly regulated, with searches being conducted weekly. The EMA conducts such searches on behalf of multiple license holders for some active ingredients in an effort to avoid duplicates and enhance data integrity. However, when it comes to the local monitoring effort, many pharma companies struggle to keep up due to large volumes of publications across several languages, and at different frequencies.